
Overview
Bradley Davis is an Oncologist in Kansas City, Kansas. Dr. Davis has been practicing medicine for over 40 years is highly rated in 10 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery. Dr. Davis is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2000 Olathe Boulevard, Kansas City, KS 66160
Olathe, KS 66062
10710 Nall Avenue, Overland Park, KS 66211
Medical Pavilion
Jeffrey Holzbeierlein is an Oncologist in Kansas City, Kansas. Dr. Holzbeierlein has been practicing medicine for over 32 years is highly rated in 42 conditions, according to our data. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Holzbeierlein is currently accepting new patients.
Kansas City Urology Care PA
Ajjai Alva is an Oncologist and a Hematologist in North Kansas City, Missouri. Dr. Alva is highly rated in 16 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Lymphadenectomy, and Nephrectomy. Dr. Alva is currently accepting new patients.
The University Of Kansas Hospital
Eugene Lee is an Oncologist in Kansas City, Kansas. Dr. Lee has been practicing medicine for over 21 years is highly rated in 31 conditions, according to our data. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Lee is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Enlarged Prostate (BPH)Dr. Davis isDistinguished. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerDr. Davis isDistinguished. Learn about Familial Prostate Cancer.
- HydroceleDr. Davis isDistinguished. Learn about Hydrocele.
- Prostate CancerDr. Davis isDistinguished. Learn about Prostate Cancer.
- Advanced
- Bladder CancerDr. Davis isAdvanced. Learn about Bladder Cancer.
- Muscle Invasive Bladder CancerDr. Davis isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- UPJ ObstructionDr. Davis isAdvanced. Learn about UPJ Obstruction.
- UreteroscopyDr. Davis isAdvanced. Learn about Ureteroscopy.
- Urothelial CancerDr. Davis isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Acute CystitisDr. Davis isExperienced. Learn about Acute Cystitis.
- Bacterial ProstatitisDr. Davis isExperienced. Learn about Bacterial Prostatitis.
- Bilateral HydronephrosisDr. Davis isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder Outlet ObstructionDr. Davis isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder StonesDr. Davis isExperienced. Learn about Bladder Stones.
- BoilsDr. Davis isExperienced. Learn about Boils.



